Differential immune responses to staphylococcal enterotoxin B mutations in a hydrophobic loop dominating the interface with major histocompatibility complex class II receptors

Journal of Infectious Diseases

Volumn 177, Issue 4, 1998, Pages 1013-1022

  Woody, Mary Alice ^a   Krakauer, Teresa ^c   Ulrich, Robert G ^c   Stiles, Bradley G ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN G3; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; STAPHYLOCOCCUS ENTEROTOXIN B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN RECOGNITION; ARTICLE; BACTERIAL MUTATION; BACTERIAL VIRULENCE; CONTROLLED STUDY; IMMUNOREACTIVITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

EID: 0031968726     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/515250     Document Type: Article

References (14)

1. Willett HP. Staphylococcus. In: Joklik WK, Willett HP, Amos DB, Wilfert CM, eds. Zinsser microbiology. 19th ed. Norwalk, CT: Appleton & Lange, 1988:343-56.
2. Bergdoll MS. Enterotoxins. In: Easmon CSF, Adlam C, eds. Staphylococci and staphylococcal infections. Vol 2. New York: Academic Press, 1983:559-98.
3. Su YC, Wong ACL. Identification and purification of a new staphylococcal enterotoxin, H. Appl Environ Microbiol 1995;61:1438-43.
4. Ren K, Bannan JD, Pancholi V, et al. Characterization and biological properties of a new staphylococcal exotoxin. J Exp Med 1994;180:1675-83.
5. Marrack P, Kappler J. The staphylococcal enterotoxins and their relatives. Science 1990;248:705-11.
6. Jardetzky TS, Brown JH, Gorga JC, et al. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature 1994;368:711-8.
7. Crass BA, Bergdoll MS. Involvement of staphylococcal enterotoxins in nonmenstrual toxic shock syndrome. J Clin Microbiol 1986;23:1138-9.
8. Lee VTP, Chang AH, Chow AW. Detection of staphylococcal enterotoxin B among toxic shock syndrome (TSS)- and non-TSS-associated Staphylococcus aureus isolates. J Infect Dis 1992;166:911-5.
9. Blackman MA, Woodland DL. In vivo effects of superantigens. Life Sci 1995;57:1717-35.
10. Schlievert PM. Role of superantigens in human disease. J Infect Dis 1993;167:997-1002.
11. Schlievert PM. Enhancement of host susceptibility to lethal shock by staphylococcal pyrogenic exotoxin type C. Infect Immun 1982;36:123-8.
12. Pettit GW, Elwell MR, Jahrling PB. Possible endotoxemia in rabbits after intravenous injection of Staphylococcus aureus enterotoxin B. J Infect Dis 1977;135:646-8.
13. Stone RL, Schlievert PM. Evidence for the involvement of endotoxin in toxic shock syndrome. J Infect Dis 1987;155:682-9.
14. Stiles BG, Bavari S, Krakauer T, Ulrich RG. Toxicity of staphylococcal enterotoxins potentiated by lipopolysaccharide: major histocompatibility complex class II molecule dependency and cytokine release. Infect Immun 1993;61:5333-8.